Literature DB >> 30678870

Feasibility and safety of enzymatic debridement for the prevention of operative escharotomy in circumferential deep burns of the distal upper extremity.

Sebastian Fischer1, Valentin Haug1, Yannick Diehm1, Patrick Rhodius1, Tomke Cordts1, Volker J Schmidt1, Dimitra Kotsougiani1, Johannes Horter1, Ulrich Kneser1, Christoph Hirche2.   

Abstract

BACKGROUND: Burn-induced compartment syndrome is a severe sequela after circumferential burns of the extremities and is avoidable by immediate release of the underlying pressure under the eschar. Although the current gold standard is operative escharotomy, this procedure carries considerable morbidity. Our study evaluates the safety and effectiveness of immediate enzymatic debridement to prevent the need for operative escharotomy because of burn-induced compartment syndrome in selected patients. PATIENTS AND METHODS: From 2015 to 2017, all patients suffering from deep circumferential burns of the upper extremities requiring operative escharotomy were potential candidates for the treatment algorithm evaluated by this study. Exclusion criteria involved burn trauma > 12 hours, clinically established burn-induced compartment syndrome, intolerance to the enzymatic debriding agent, dry burns requiring presoaking, as well as blast and electrical injuries requiring fasciotomy or carpal tunnel release. All patients with the inclusion criteria received enzymatic debridement with Nexobrid immediately after admission to our burn center. Enzymatic debridement was applied according to the manufacturer's recommendations. After enzymatic debridement, extremities were revisited every 2 hours for 24 hours to determine the need for conversion to conventional operative escharotomy. The indication for and time to skin grafting was reviewed, and functional outcomes assessed during follow-up examination.
RESULTS: Included in this sturdy were 13 patients with 20 burned upper extremities. Enzymatic debridement provided a sufficient eschar removal in all patients. Conversion to conventional operative escharotomy was thus not necessary in any patient. Secondary skin grafting was required in 9 patients. Functional outcomes were favorable 11.9 months after burn trauma.
CONCLUSION: If the specific contraindications are respected, enzymatic debridement is safe and effective for the prevention of burn-induced compartment syndrome after deep circumferential burns at the upper extremity, and thus making operative escharotomy unnecessary.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30678870     DOI: 10.1016/j.surg.2018.11.019

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Late-Onset Acute Kidney Injury is a Poor Prognostic Sign for Severe Burn Patients.

Authors:  Bo You; Zichen Yang; Yulong Zhang; Yu Chen; Yali Gong; Yajie Chen; Jing Chen; Lili Yuan; Gaoxing Luo; Yizhi Peng; Zhiqiang Yuan
Journal:  Front Surg       Date:  2022-05-02

2.  Historical Perspectives on the Development of Current Standards of Care for Enzymatic Debridement.

Authors:  Wolfram Heitzmann; Paul Christian Fuchs; Jennifer Lynn Schiefer
Journal:  Medicina (Kaunas)       Date:  2020-12-17       Impact factor: 2.430

3.  Bromelain-based enzymatic burn debridement: Spanish multidisciplinary consensus.

Authors:  Jordi Serracanta; Jacinto Baena; José R Martinez-Mendez; Manuel Sanchez-Sanchez; Eugenia Lopez-Suso; Rita Galeiras; Maria Dolores Perez-Del-Caz; Carmen Vivo-Benlloch; Enrique Monclus-Fuertes; Jacobo Casalduero-Viu; Patricia Martin-Playa; Marta Ugalde-Gutierrez; Purificacion Gacto-Sanchez; Maria Dolores Rincon-Ferrari; Jose Maria Piqueras-Perez; Ana Martin-Luengo
Journal:  Eur J Plast Surg       Date:  2022-09-29

4.  A Questionnaire-Based Study to Obtain a Consensus from 5 Polish Burns Centers on Eschar Removal by Bromelain-Based Enzymatic Debridement (Nexobrid®) in Burns Following the 2020 Updated European Consensus Guidelines.

Authors:  Tomasz Korzeniowski; Jerzy Strużyna; Anna M Chrapusta; Andrzej Krajewski; Marek Kucharzewski; Krzysztof Piorun; Jakub Nowakowski; Agnieszka Surowiecka; Magdalena Kozicka; Kamil Torres
Journal:  Med Sci Monit       Date:  2022-01-22

5.  Enzymatic Debridement for Burn Wound Care: Interrater Reliability and Impact of Experience in Post-intervention Therapy Decision.

Authors:  Laura C Siegwart; Arne H Böcker; Yannick F Diehm; Dimitra Kotsougiani-Fischer; Stella Erdmann; Benjamin Ziegler; Ulrich Kneser; Christoph Hirche; Sebastian Fischer
Journal:  J Burn Care Res       Date:  2021-09-30       Impact factor: 1.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.